2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 130 filers reported holding 2SEVENTY BIO INC in Q2 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $10,714,539 | -68.5% | 1,143,494 | -51.2% | 0.33% | -67.6% |
Q3 2022 | $34,066,000 | -26.2% | 2,341,313 | -33.0% | 1.00% | -36.9% |
Q2 2022 | $46,146,000 | -22.6% | 3,495,943 | 0.0% | 1.59% | -14.6% |
Q1 2022 | $59,641,000 | +21.4% | 3,495,943 | +82.4% | 1.87% | +19.2% |
Q4 2021 | $49,134,000 | – | 1,917,063 | – | 1.57% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 5,953,825 | $23,338,994 | 3.82% |
Newtyn Management, LLC | 3,076,490 | $12,059,841 | 2.98% |
DAFNA Capital Management LLC | 1,447,465 | $5,674,063 | 1.76% |
CHI Advisors LLC | 1,002,007 | $3,927,867 | 1.56% |
AlphaCentric Advisors LLC | 657,500 | $2,577,400 | 1.46% |
Casdin Capital, LLC | 2,023,913 | $7,933,739 | 0.88% |
Madison Avenue Partners, LP | 1,494,125 | $5,856,970 | 0.83% |
Bain Capital Life Sciences Investors, LLC | 1,408,901 | $5,522,892 | 0.62% |
Eversept Partners, LP | 1,453,378 | $5,697,242 | 0.48% |
Engine Capital Management, LP | 341,870 | $1,340,130 | 0.30% |